FTSE 100
8.600,28
PKT
+40,95
PKT
+0,48
%
Werbung
Analysen zu FTSE 100-Werten
Datum | Rating | Analyst | |
---|---|---|---|
30.01.25 | GSK Underweight | JP Morgan Chase & Co. | |
30.01.25 | Diageo Neutral | JP Morgan Chase & Co. | |
30.01.25 | GSK Neutral | UBS AG | |
30.01.25 | AstraZeneca Neutral | UBS AG | |
30.01.25 | Shell (ex Royal Dutch Shell) Outperform | RBC Capital Markets | |
30.01.25 | Shell (ex Royal Dutch Shell) Buy | UBS AG | |
30.01.25 | Shell (ex Royal Dutch Shell) Buy | Goldman Sachs Group Inc. | |
28.01.25 | Shell (ex Royal Dutch Shell) Outperform | RBC Capital Markets | |
28.01.25 | BAT Buy | Deutsche Bank AG | |
27.01.25 | Diageo Buy | Jefferies & Company Inc. | |
27.01.25 | Diageo Sector Perform | RBC Capital Markets | |
27.01.25 | Diageo Buy | UBS AG | |
24.01.25 | Diageo Buy | UBS AG | |
24.01.25 | Reckitt Benckiser Outperform | RBC Capital Markets | |
24.01.25 | HSBC Neutral | JP Morgan Chase & Co. | |
24.01.25 | Rio Tinto Neutral | UBS AG | |
24.01.25 | BP Buy | UBS AG | |
24.01.25 | Shell (ex Royal Dutch Shell) Buy | UBS AG | |
24.01.25 | Diageo Outperform | Bernstein Research | |
23.01.25 | easyJet Buy | UBS AG | |
23.01.25 | Vodafone Group Underperform | Bernstein Research | |
23.01.25 | Unilever Overweight | JP Morgan Chase & Co. | |
23.01.25 | Reckitt Benckiser Neutral | JP Morgan Chase & Co. | |
23.01.25 | easyJet Buy | Deutsche Bank AG | |
23.01.25 | Vodafone Group Buy | Deutsche Bank AG | |
23.01.25 | Diageo Buy | UBS AG | |
23.01.25 | London Stock Exchange (LSE) Buy | UBS AG | |
23.01.25 | easyJet Market-Perform | Bernstein Research | |
22.01.25 | easyJet Neutral | Goldman Sachs Group Inc. | |
22.01.25 | BP Sector Perform | RBC Capital Markets | |
22.01.25 | easyJet Sector Perform | RBC Capital Markets | |
22.01.25 | easyJet Buy | UBS AG | |
22.01.25 | Rolls-Royce Buy | Jefferies & Company Inc. | |
22.01.25 | London Stock Exchange (LSE) Hold | Deutsche Bank AG | |
22.01.25 | easyJet Market-Perform | Bernstein Research | |
22.01.25 | BP Buy | UBS AG | |
22.01.25 | easyJet Overweight | JP Morgan Chase & Co. | |
21.01.25 | Vodafone Group Neutral | UBS AG | |
21.01.25 | RELX Overweight | JP Morgan Chase & Co. | |
21.01.25 | AstraZeneca Buy | Goldman Sachs Group Inc. |
* Die angezeigten Realtime Kurse sind indikativ und nicht die offiziellen Börsenkurse. Die Kursdaten können eventuell vom tatsächlichen Marktpreis abweichen.